Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment.

MLA

Tran, Thi-Van-Trinh, et al. “Breast Cancer Risk among Thyroid Cancer Survivors and the Role of I-131 Treatment.” British Journal of Cancer, vol. 127, no. 12, Dec. 2022, pp. 2118–24. EBSCOhost, https://doi.org/10.1038/s41416-022-01982-5.

APA

Tran, T.-V.-T., Rubino, C., Allodji, R., Andruccioli, M., Bardet, S., Diallo, I., Dottorini, M., Garsi, J., Hall, P., Henry-Amar, M., Lamart, S., Le Thai, F., Lönn, S., Ricard, M., Schvartz, C., Schlumberger, M., Journy, N., & de Vathaire, F. (2022). Breast cancer risk among thyroid cancer survivors and the role of I-131 treatment. British Journal of Cancer, 127(12), 2118–2124. https://doi.org/10.1038/s41416-022-01982-5

Chicago

Tran, Thi-Van-Trinh, Carole Rubino, Rodrigue Allodji, Milena Andruccioli, Stéphane Bardet, Ibrahima Diallo, Massimo Dottorini, et al. 2022. “Breast Cancer Risk among Thyroid Cancer Survivors and the Role of I-131 Treatment.” British Journal of Cancer 127 (12): 2118–24. doi:10.1038/s41416-022-01982-5.